Table 4.
Antimicrobial and other bioactive peptides produced by the intein‐mediated systemThe peptides labelled with an asterisk (*) are antimicrobial peptides. Size is shown as the number of amino acid residues. Further abbreviations used: ABP‐CM4, antibacterial peptide CM4 (see Table 1); Bin‐1b, an antimicrobial‐like protein also known as sperm‐associated antigen 11 precursor; hBNP, human brain natriuretic peptide; hEGF, human epidermal growth factor; M65, a deletion mutant of Maxadilan, a vasodilator peptide isolated from sandfly salivary glands; rhPACAP, recombinant human pituitary adenylate cyclase‐activating polypeptide; rMBAY, a peptide designed to imitate BAY 55‐9837, a VPAC2 (vasoactive intestinal peptide receptor 2)‐selective agonist developed by Bayer Corporation; rMROM, a 32‐amino‐acid VPAC2 agonist; SMAP‐29, sheep myeloid antimicrobial peptide 29.
| Peptide | Size | Fusion solubility | Yield (mg/litre) | Reference |
|---|---|---|---|---|
| ABP‐CM4* | 35 | Soluble | 4.2 | [60] |
| Aldolase A fragment | 26 | Soluble | 1.4 | [77] |
| β‐Defensin 1* | 37 | Partially soluble | 4.5 | [78] |
| β‐Defensin 2* | 41 | Partially soluble | 4.1 | [78] |
| Bin‐1b* | 49 | Partially soluble | 3.2 | [78] |
| Divercin V41* | 43 | Soluble | NAa | [79] |
| Enterocin P* | 44 | Soluble | NA | [79] |
| Glucagon | 29 | Partially soluble | 11.9 | [80] |
| hBNP | 32 | Insoluble | 2.4 | [81] |
| hEGF | 53 | Insoluble | 17–18 | [82] |
| Huwentoxin‐1 | 33 | Soluble | 7.8 | [83] |
| Maxadilan | 67 | Soluble | 5.0 | [84] |
| M65 | 50 | Soluble | 5.3 | [84] |
| Pediocin PA‐1* | 44 | Soluble | NA | [79] |
| Piscicolin 126* | 44 | Soluble | 1.1 | [79] |
| rhPACAP | 39 | Soluble | 22 | [85] |
| rMBAY | 32 | Soluble | 53 | [86] |
| rMROM | 32 | Soluble | 6.8 | [87] |
| SMAP‐29* | 29 | Soluble | 0.1–0.2 | [88] |
Not available.